US Patent Issued to Eli Lilly and Co. on Nov. 25 for "2-[2-methylazetidin-1-yl-4-phenyl-6-(trifluoromethyl)-pyrimidine compounds" (Indiana Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,829, issued on Nov. 25, was assigned to Eli Lilly and Co. (Indianapolis).

"2-[2-methylazetidin-1-yl-4-phenyl-6-(trifluoromethyl)-pyrimidine compounds" was invented by Timothy Barrett Durham (Indianapolis), Junliang Hao (Carmel, Ind.) and Richard Duane Johnston (Greenfield, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula (I) for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis."

The patent was filed on Feb. 5, 2021, un...